| Non-Hodgkin Lymphoma (NHL) |
1 |
1 |
| Biologic Therapy |
0 |
0.98 |
| CAR-T |
0 |
0.75 |
| B-Cell Lymphoma |
0 |
1 |
| Hodgkin Lymphoma |
0 |
0.41 |
| Lymphoma |
0 |
0.41 |
| Mantle Cell Lymphoma |
0 |
0.85 |
| Biomarker |
0 |
0.55 |
| Antineoplastic Drug |
0 |
0.1 |
| Cytokines |
0 |
0.1 |
| Monoclonal Antibody |
0 |
0.1 |
| CT Scan |
0 |
0.65 |
| Tyrosine Kinase Inhibitor |
0 |
0.55 |
| Healthcare and Medical Technology |
0 |
0.06 |